Global Liposomal Drug-delivery System Market Size, Status and Forecast 2024-2031

Report ID: 923018 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Liposomal Drug-delivery System Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Liposome Vitamin
        1.2.3 Liposome Ceramide
        1.2.4 Liposome CoQ10
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Liposomal Drug-delivery System Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Medical
        1.3.3 Cosmetics
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Liposomal Drug-delivery System Market Perspective (2016-2027)
    2.2 Liposomal Drug-delivery System Growth Trends by Regions
        2.2.1 Liposomal Drug-delivery System Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Liposomal Drug-delivery System Historic Market Share by Regions (2016-2021)
        2.2.3 Liposomal Drug-delivery System Forecasted Market Size by Regions (2022-2027)
    2.3 Liposomal Drug-delivery System Industry Dynamic
        2.3.1 Liposomal Drug-delivery System Market Trends
        2.3.2 Liposomal Drug-delivery System Market Drivers
        2.3.3 Liposomal Drug-delivery System Market Challenges
        2.3.4 Liposomal Drug-delivery System Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Liposomal Drug-delivery System Players by Revenue
        3.1.1 Global Top Liposomal Drug-delivery System Players by Revenue (2016-2021)
        3.1.2 Global Liposomal Drug-delivery System Revenue Market Share by Players (2016-2021)
    3.2 Global Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Liposomal Drug-delivery System Revenue
    3.4 Global Liposomal Drug-delivery System Market Concentration Ratio
        3.4.1 Global Liposomal Drug-delivery System Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug-delivery System Revenue in 2020
    3.5 Liposomal Drug-delivery System Key Players Head office and Area Served
    3.6 Key Players Liposomal Drug-delivery System Product Solution and Service
    3.7 Date of Enter into Liposomal Drug-delivery System Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Liposomal Drug-delivery System Breakdown Data by Type
    4.1 Global Liposomal Drug-delivery System Historic Market Size by Type (2016-2021)
    4.2 Global Liposomal Drug-delivery System Forecasted Market Size by Type (2022-2027)

5 Liposomal Drug-delivery System Breakdown Data by Application
    5.1 Global Liposomal Drug-delivery System Historic Market Size by Application (2016-2021)
    5.2 Global Liposomal Drug-delivery System Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Liposomal Drug-delivery System Market Size (2016-2027)
    6.2 North America Liposomal Drug-delivery System Market Size by Type
        6.2.1 North America Liposomal Drug-delivery System Market Size by Type (2016-2021)
        6.2.2 North America Liposomal Drug-delivery System Market Size by Type (2022-2027)
        6.2.3 North America Liposomal Drug-delivery System Market Size by Type (2016-2027)
    6.3 North America Liposomal Drug-delivery System Market Size by Application
        6.3.1 North America Liposomal Drug-delivery System Market Size by Application (2016-2021)
        6.3.2 North America Liposomal Drug-delivery System Market Size by Application (2022-2027)
        6.3.3 North America Liposomal Drug-delivery System Market Size by Application (2016-2027)
    6.4 North America Liposomal Drug-delivery System Market Size by Country
        6.4.1 North America Liposomal Drug-delivery System Market Size by Country (2016-2021)
        6.4.2 North America Liposomal Drug-delivery System Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Liposomal Drug-delivery System Market Size (2016-2027)
    7.2 Europe Liposomal Drug-delivery System Market Size by Type
        7.2.1 Europe Liposomal Drug-delivery System Market Size by Type (2016-2021)
        7.2.2 Europe Liposomal Drug-delivery System Market Size by Type (2022-2027)
        7.2.3 Europe Liposomal Drug-delivery System Market Size by Type (2016-2027)
    7.3 Europe Liposomal Drug-delivery System Market Size by Application
        7.3.1 Europe Liposomal Drug-delivery System Market Size by Application (2016-2021)
        7.3.2 Europe Liposomal Drug-delivery System Market Size by Application (2022-2027)
        7.3.3 Europe Liposomal Drug-delivery System Market Size by Application (2016-2027)
    7.4 Europe Liposomal Drug-delivery System Market Size by Country
        7.4.1 Europe Liposomal Drug-delivery System Market Size by Country (2016-2021)
        7.4.2 Europe Liposomal Drug-delivery System Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Liposomal Drug-delivery System Market Size (2016-2027)
    8.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Type
        8.2.1 Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2016-2027)
    8.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Application
        8.3.1 Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2016-2027)
    8.4 Asia-Pacific Liposomal Drug-delivery System Market Size by Region
        8.4.1 Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Liposomal Drug-delivery System Market Size (2016-2027)
    9.2 Latin America Liposomal Drug-delivery System Market Size by Type
        9.2.1 Latin America Liposomal Drug-delivery System Market Size by Type (2016-2021)
        9.2.2 Latin America Liposomal Drug-delivery System Market Size by Type (2022-2027)
        9.2.3 Latin America Liposomal Drug-delivery System Market Size by Type (2016-2027)
    9.3 Latin America Liposomal Drug-delivery System Market Size by Application
        9.3.1 Latin America Liposomal Drug-delivery System Market Size by Application (2016-2021)
        9.3.2 Latin America Liposomal Drug-delivery System Market Size by Application (2022-2027)
        9.3.3 Latin America Liposomal Drug-delivery System Market Size by Application (2016-2027)
    9.4 Latin America Liposomal Drug-delivery System Market Size by Country
        9.4.1 Latin America Liposomal Drug-delivery System Market Size by Country (2016-2021)
        9.4.2 Latin America Liposomal Drug-delivery System Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Liposomal Drug-delivery System Market Size (2016-2027)
    10.2 Middle East & Africa Liposomal Drug-delivery System Market Size by Type
        10.2.1 Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2016-2027)
    10.3 Middle East & Africa Liposomal Drug-delivery System Market Size by Application
        10.3.1 Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2016-2027)
    10.4 Middle East & Africa Liposomal Drug-delivery System Market Size by Country
        10.4.1 Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Lipoid Kosmetik
        11.1.1 Lipoid Kosmetik Company Details
        11.1.2 Lipoid Kosmetik Business Overview
        11.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Introduction
        11.1.4 Lipoid Kosmetik Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.1.5 Lipoid Kosmetik Recent Development
    11.2 Lucas Meyer Cosmetics
        11.2.1 Lucas Meyer Cosmetics Company Details
        11.2.2 Lucas Meyer Cosmetics Business Overview
        11.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Introduction
        11.2.4 Lucas Meyer Cosmetics Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.2.5 Lucas Meyer Cosmetics Recent Development
    11.3 Nippon Fine Chemical
        11.3.1 Nippon Fine Chemical Company Details
        11.3.2 Nippon Fine Chemical Business Overview
        11.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Introduction
        11.3.4 Nippon Fine Chemical Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.3.5 Nippon Fine Chemical Recent Development
    11.4 Enoc Solutions
        11.4.1 Enoc Solutions Company Details
        11.4.2 Enoc Solutions Business Overview
        11.4.3 Enoc Solutions Liposomal Drug-delivery System Introduction
        11.4.4 Enoc Solutions Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.4.5 Enoc Solutions Recent Development
    11.5 Nanovec
        11.5.1 Nanovec Company Details
        11.5.2 Nanovec Business Overview
        11.5.3 Nanovec Liposomal Drug-delivery System Introduction
        11.5.4 Nanovec Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.5.5 Nanovec Recent Development
    11.6 Lipotec
        11.6.1 Lipotec Company Details
        11.6.2 Lipotec Business Overview
        11.6.3 Lipotec Liposomal Drug-delivery System Introduction
        11.6.4 Lipotec Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.6.5 Lipotec Recent Development
    11.7 Croda
        11.7.1 Croda Company Details
        11.7.2 Croda Business Overview
        11.7.3 Croda Liposomal Drug-delivery System Introduction
        11.7.4 Croda Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.7.5 Croda Recent Development
    11.8 H&A Pharmachem
        11.8.1 H&A Pharmachem Company Details
        11.8.2 H&A Pharmachem Business Overview
        11.8.3 H&A Pharmachem Liposomal Drug-delivery System Introduction
        11.8.4 H&A Pharmachem Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.8.5 H&A Pharmachem Recent Development
    11.9 Lipomize
        11.9.1 Lipomize Company Details
        11.9.2 Lipomize Business Overview
        11.9.3 Lipomize Liposomal Drug-delivery System Introduction
        11.9.4 Lipomize Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.9.5 Lipomize Recent Development
    11.10 ID bio
        11.10.1 ID bio Company Details
        11.10.2 ID bio Business Overview
        11.10.3 ID bio Liposomal Drug-delivery System Introduction
        11.10.4 ID bio Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.10.5 ID bio Recent Development
    11.11 BioSpectrum
        11.11.1 BioSpectrum Company Details
        11.11.2 BioSpectrum Business Overview
        11.11.3 BioSpectrum Liposomal Drug-delivery System Introduction
        11.11.4 BioSpectrum Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.11.5 BioSpectrum Recent Development
    11.12 Derma Clinical
        11.12.1 Derma Clinical Company Details
        11.12.2 Derma Clinical Business Overview
        11.12.3 Derma Clinical Liposomal Drug-delivery System Introduction
        11.12.4 Derma Clinical Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.12.5 Derma Clinical Recent Development
    11.13 Kewpie Corporation
        11.13.1 Kewpie Corporation Company Details
        11.13.2 Kewpie Corporation Business Overview
        11.13.3 Kewpie Corporation Liposomal Drug-delivery System Introduction
        11.13.4 Kewpie Corporation Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.13.5 Kewpie Corporation Recent Development
    11.14 Nanohealth Biotech
        11.14.1 Nanohealth Biotech Company Details
        11.14.2 Nanohealth Biotech Business Overview
        11.14.3 Nanohealth Biotech Liposomal Drug-delivery System Introduction
        11.14.4 Nanohealth Biotech Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.14.5 Nanohealth Biotech Recent Development
    11.15 Creative Biostructure
        11.15.1 Creative Biostructure Company Details
        11.15.2 Creative Biostructure Business Overview
        11.15.3 Creative Biostructure Liposomal Drug-delivery System Introduction
        11.15.4 Creative Biostructure Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.15.5 Creative Biostructure Recent Development
    11.16 Phenbiox
        11.16.1 Phenbiox Company Details
        11.16.2 Phenbiox Business Overview
        11.16.3 Phenbiox Liposomal Drug-delivery System Introduction
        11.16.4 Phenbiox Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.16.5 Phenbiox Recent Development
    11.17 NOF CORPORATION
        11.17.1 NOF CORPORATION Company Details
        11.17.2 NOF CORPORATION Business Overview
        11.17.3 NOF CORPORATION Liposomal Drug-delivery System Introduction
        11.17.4 NOF CORPORATION Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.17.5 NOF CORPORATION Recent Development
    11.18 KYOWA PHARMA CHEMICAL
        11.18.1 KYOWA PHARMA CHEMICAL Company Details
        11.18.2 KYOWA PHARMA CHEMICAL Business Overview
        11.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Introduction
        11.18.4 KYOWA PHARMA CHEMICAL Revenue in Liposomal Drug-delivery System Business (2016-2021)
        11.18.5 KYOWA PHARMA CHEMICAL Recent Development
    11.18 Nikko Chemicals
        .1 Nikko Chemicals Company Details
        .2 Nikko Chemicals Business Overview
        .3 Nikko Chemicals Liposomal Drug-delivery System Introduction
        .4 Nikko Chemicals Revenue in Liposomal Drug-delivery System Business (2016-2021)
        .5 Nikko Chemicals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Liposomal Drug-delivery System Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposome Vitamin
    Table 3. Key Players of Liposome Ceramide
    Table 4. Key Players of Liposome CoQ10
    Table 5. Key Players of Others
    Table 6. Global Liposomal Drug-delivery System Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Liposomal Drug-delivery System Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Liposomal Drug-delivery System Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Liposomal Drug-delivery System Market Share by Regions (2016-2021)
    Table 10. Global Liposomal Drug-delivery System Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Liposomal Drug-delivery System Market Share by Regions (2022-2027)
    Table 12. Liposomal Drug-delivery System Market Trends
    Table 13. Liposomal Drug-delivery System Market Drivers
    Table 14. Liposomal Drug-delivery System Market Challenges
    Table 15. Liposomal Drug-delivery System Market Restraints
    Table 16. Global Liposomal Drug-delivery System Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Liposomal Drug-delivery System Market Share by Players (2016-2021)
    Table 18. Global Top Liposomal Drug-delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Drug-delivery System as of 2020)
    Table 19. Ranking of Global Top Liposomal Drug-delivery System Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Liposomal Drug-delivery System Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Liposomal Drug-delivery System Product Solution and Service
    Table 23. Date of Enter into Liposomal Drug-delivery System Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Liposomal Drug-delivery System Revenue Market Share by Type (2016-2021)
    Table 27. Global Liposomal Drug-delivery System Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Liposomal Drug-delivery System Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Liposomal Drug-delivery System Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Liposomal Drug-delivery System Revenue Market Share by Application (2016-2021)
    Table 31. Global Liposomal Drug-delivery System Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Liposomal Drug-delivery System Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Liposomal Drug-delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Liposomal Drug-delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Liposomal Drug-delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Liposomal Drug-delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Liposomal Drug-delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Liposomal Drug-delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Liposomal Drug-delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Liposomal Drug-delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Liposomal Drug-delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Liposomal Drug-delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Liposomal Drug-delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Liposomal Drug-delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Liposomal Drug-delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Liposomal Drug-delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Liposomal Drug-delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Lipoid Kosmetik Company Details
    Table 64. Lipoid Kosmetik Business Overview
    Table 65. Lipoid Kosmetik Liposomal Drug-delivery System Product
    Table 66. Lipoid Kosmetik Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 67. Lipoid Kosmetik Recent Development
    Table 68. Lucas Meyer Cosmetics Company Details
    Table 69. Lucas Meyer Cosmetics Business Overview
    Table 70. Lucas Meyer Cosmetics Liposomal Drug-delivery System Product
    Table 71. Lucas Meyer Cosmetics Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 72. Lucas Meyer Cosmetics Recent Development
    Table 73. Nippon Fine Chemical Company Details
    Table 74. Nippon Fine Chemical Business Overview
    Table 75. Nippon Fine Chemical Liposomal Drug-delivery System Product
    Table 76. Nippon Fine Chemical Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 77. Nippon Fine Chemical Recent Development
    Table 78. Enoc Solutions Company Details
    Table 79. Enoc Solutions Business Overview
    Table 80. Enoc Solutions Liposomal Drug-delivery System Product
    Table 81. Enoc Solutions Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 82. Enoc Solutions Recent Development
    Table 83. Nanovec Company Details
    Table 84. Nanovec Business Overview
    Table 85. Nanovec Liposomal Drug-delivery System Product
    Table 86. Nanovec Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 87. Nanovec Recent Development
    Table 88. Lipotec Company Details
    Table 89. Lipotec Business Overview
    Table 90. Lipotec Liposomal Drug-delivery System Product
    Table 91. Lipotec Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 92. Lipotec Recent Development
    Table 93. Croda Company Details
    Table 94. Croda Business Overview
    Table 95. Croda Liposomal Drug-delivery System Product
    Table 96. Croda Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 97. Croda Recent Development
    Table 98. H&A Pharmachem Company Details
    Table 99. H&A Pharmachem Business Overview
    Table 100. H&A Pharmachem Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 101. H&A Pharmachem Recent Development
    Table 102. Lipomize Company Details
    Table 103. Lipomize Business Overview
    Table 104. Lipomize Liposomal Drug-delivery System Product
    Table 105. Lipomize Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 106. Lipomize Recent Development
    Table 107. ID bio Company Details
    Table 108. ID bio Business Overview
    Table 109. ID bio Liposomal Drug-delivery System Product
    Table 110. ID bio Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 111. ID bio Recent Development
    Table 112. BioSpectrum Company Details
    Table 113. BioSpectrum Business Overview
    Table 114. BioSpectrum Liposomal Drug-delivery System Product
    Table 115. BioSpectrum Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 116. BioSpectrum Recent Development
    Table 117. Derma Clinical Company Details
    Table 118. Derma Clinical Business Overview
    Table 119. Derma Clinical Liposomal Drug-delivery System Product
    Table 120. Derma Clinical Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 121. Derma Clinical Recent Development
    Table 122. Kewpie Corporation Company Details
    Table 123. Kewpie Corporation Business Overview
    Table 124. Kewpie Corporation Liposomal Drug-delivery System Product
    Table 125. Kewpie Corporation Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 126. Kewpie Corporation Recent Development
    Table 127. Nanohealth Biotech Company Details
    Table 128. Nanohealth Biotech Business Overview
    Table 129. Nanohealth Biotech Liposomal Drug-delivery System Product
    Table 130. Nanohealth Biotech Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 131. Nanohealth Biotech Recent Development
    Table 132. Creative Biostructure Company Details
    Table 133. Creative Biostructure Business Overview
    Table 134. Creative Biostructure Liposomal Drug-delivery System Product
    Table 135. Creative Biostructure Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 136. Creative Biostructure Recent Development
    Table 137. Phenbiox Company Details
    Table 138. Phenbiox Business Overview
    Table 139. Phenbiox Liposomal Drug-delivery System Product
    Table 140. Phenbiox Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 141. Phenbiox Recent Development
    Table 142. NOF CORPORATION Company Details
    Table 143. NOF CORPORATION Business Overview
    Table 144. NOF CORPORATION Liposomal Drug-delivery System Product
    Table 145. NOF CORPORATION Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 146. NOF CORPORATION Recent Development
    Table 147. KYOWA PHARMA CHEMICAL Company Details
    Table 148. KYOWA PHARMA CHEMICAL Business Overview
    Table 149. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product
    Table 150. KYOWA PHARMA CHEMICAL Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 151. KYOWA PHARMA CHEMICAL Recent Development
    Table 152. Nikko Chemicals Company Details
    Table 153. Nikko Chemicals Business Overview
    Table 154. Nikko Chemicals Liposomal Drug-delivery System Product
    Table 155. Nikko Chemicals Revenue in Liposomal Drug-delivery System Business (2016-2021) & (US$ Million)
    Table 156. Nikko Chemicals Recent Development
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liposomal Drug-delivery System Market Share by Type: 2020 VS 2027
    Figure 2. Liposome Vitamin Features
    Figure 3. Liposome Ceramide Features
    Figure 4. Liposome CoQ10 Features
    Figure 5. Others Features
    Figure 6. Global Liposomal Drug-delivery System Market Share by Application: 2020 VS 2027
    Figure 7. Medical Case Studies
    Figure 8. Cosmetics Case Studies
    Figure 9. Liposomal Drug-delivery System Report Years Considered
    Figure 10. Global Liposomal Drug-delivery System Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Liposomal Drug-delivery System Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Liposomal Drug-delivery System Market Share by Regions: 2020 VS 2027
    Figure 13. Global Liposomal Drug-delivery System Market Share by Regions (2022-2027)
    Figure 14. Global Liposomal Drug-delivery System Market Share by Players in 2020
    Figure 15. Global Top Liposomal Drug-delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Drug-delivery System as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Liposomal Drug-delivery System Revenue in 2020
    Figure 17. Global Liposomal Drug-delivery System Revenue Market Share by Type (2016-2021)
    Figure 18. Global Liposomal Drug-delivery System Revenue Market Share by Type (2022-2027)
    Figure 19. North America Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Liposomal Drug-delivery System Market Share by Type (2016-2027)
    Figure 21. North America Liposomal Drug-delivery System Market Share by Application (2016-2027)
    Figure 22. North America Liposomal Drug-delivery System Market Share by Country (2016-2027)
    Figure 23. United States Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Liposomal Drug-delivery System Market Share by Type (2016-2027)
    Figure 27. Europe Liposomal Drug-delivery System Market Share by Application (2016-2027)
    Figure 28. Europe Liposomal Drug-delivery System Market Share by Country (2016-2027)
    Figure 29. Germany Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Liposomal Drug-delivery System Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Liposomal Drug-delivery System Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Liposomal Drug-delivery System Market Share by Region (2016-2027)
    Figure 39. China Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Liposomal Drug-delivery System Market Share by Type (2016-2027)
    Figure 47. Latin America Liposomal Drug-delivery System Market Share by Application (2016-2027)
    Figure 48. Latin America Liposomal Drug-delivery System Market Share by Country (2016-2027)
    Figure 49. Mexico Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Liposomal Drug-delivery System Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Liposomal Drug-delivery System Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Liposomal Drug-delivery System Market Share by Country (2016-2027)
    Figure 55. Turkey Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Liposomal Drug-delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Lipoid Kosmetik Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 59. Lucas Meyer Cosmetics Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 60. Nippon Fine Chemical Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 61. Enoc Solutions Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 62. Nanovec Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 63. Lipotec Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 64. Croda Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 65. H&A Pharmachem Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 66. Lipomize Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 67. ID bio Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 68. BioSpectrum Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 69. Derma Clinical Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 70. Kewpie Corporation Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 71. Nanohealth Biotech Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 72. Creative Biostructure Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 73. Phenbiox Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 74. NOF CORPORATION Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 75. KYOWA PHARMA CHEMICAL Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 76. Nikko Chemicals Revenue Growth Rate in Liposomal Drug-delivery System Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Frequently Asked Questions
Liposomal Drug-delivery System report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liposomal Drug-delivery System report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liposomal Drug-delivery System report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports